Paths of Progress
Sapna Syngal,MD, MPH, and Michael Carlin discuss his family's risk for pancreatic and other cancers.
Fall/Winter 2005
Volume 14, Number 2
Contents
Features
- Making cancer cells die a 'good death'
By Richard Saltus
Dana-Farber researchers are harnessing programmed cell death, or apoptosis, to attack tumors. Figuring out how cells avoid this process and become cancerous may hold one key to cures. - Transplanting cells and hope in young patients
By Christine Cleary
The pediatric stem cell transplantation program at Dana-Farber Children's Hospital Cancer Care offers youngsters battling cancer, blood diseases, and immune disorders a new lease on life. - The promise of the 'A' word
By Robert Levy
Once debunked and then heralded as a cancer cure, antiangiogenic therapies—which aim to shrink tumors by cutting off their blood supply—are now progressing at a rapid pace. - Making Dana-Farber more resource-full
By Robert Levy
As their participation in clinical and basic research grows increasingly high tech, DFCI scientists share additional findings and insights with each other—and the world. - Pancreatic cancer: Back to basics
By Richard Saltus
Added attention and funding, along with promising clinical trials, are giving staff at Dana-Farber and elsewhere new confidence that they can thwart this silent keller. - Glorian Sorensen takes a global view of tobacco use
By Debra Ruder
During an eye-opening trip to India, the DFCI investigator studied the alarming rates of tobacco consumption among the country's teachers, workers, and youths.
Departments
- Dateline DFCI
Recent Institute news, including steps toward meeting strategic goals and reducing health desparities - Discoveries
Research findings on brain gene activity, the development of melanoma, and more - First Person: Stories of courage and grace
- From the President
Credits
President, Dana-Farber Cancer Institute Edward J. Benz Jr., MD
Chief of Staff Stephen E. Sallan, MD
Chief Medical Officer Lawrence N. Shulman, MD
Chief Scientific Officer Barrett Rollins, MD
Chair, Medical Oncology James D. Griffin, MD
Chair, Pediatric Oncology Stuart H. Orkin, MD
Chair, Radiation Oncology Jay R. Harris, MD
Chair, Executive Committee for Research Stanley J. Korsmeyer, MD*
Senior VP for Experimental Medicine Lee M. Nadler, MD
Senior VP for Patient Care Services, Chief of Nursing Patricia Reid Ponte, RN, DNSc, FAAN
Senior VP for Research Faye C. Austin, PhD
Senior VP for Communications Steven R. Singer
Director of Publications Paul Hennessy
Editor Debra Ruder
Associate Editor Saul Wisnia
Staff Writers Christine Cleary, Robert Levy, Joe O'Shea, Richard Saltus
Design John DiGianni
Production Assistance Lonnie Christiansen, Patricia Cleary, Caroline Kraunelis, Kristin Lacey
Photography C.J. Allen, William Bonney, Steve Gilbert, Shawn Henry,
Bill Horsman, Phillip Porcella, Laura Wulf
* Passed away March 31, 2005
Paths of Progress is published twice a year by Dana-Farber Cancer Institute's Department of Communications. If you have any comments or would like to be removed from the mailing list, contact:
Debra Ruder (debra_ruder@dfci.harvard.edu)
Editor, Paths of Progress
Dana-Farber Cancer Institute, Department of Communications
375 Longwood Ave., Boston, MA 02215-6084
(617) 632-4090
Copyright © 2005 Dana-Farber Cancer Institute. All rights reserved.
